These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 9651632)

  • 1. Immunogenicity of hepatitis B Vaccines. Implications for persons at occupational risk of hepatitis B virus infection.
    Averhoff F; Mahoney F; Coleman P; Schatz G; Hurwitz E; Margolis H
    Am J Prev Med; 1998 Jul; 15(1):1-8. PubMed ID: 9651632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Durability of antibody response against hepatitis B virus in healthcare workers vaccinated as adults.
    Gara N; Abdalla A; Rivera E; Zhao X; Werner JM; Liang TJ; Hoofnagle JH; Rehermann B; Ghany MG
    Clin Infect Dis; 2015 Feb; 60(4):505-13. PubMed ID: 25389254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of an age-response relationship to GSK's recombinant hepatitis B vaccine in healthy adults: An integrated analysis.
    Van Der Meeren O; Crasta P; Cheuvart B; De Ridder M
    Hum Vaccin Immunother; 2015; 11(7):1726-9. PubMed ID: 25996260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health care workers in Pearl River Delta Area of China are not vaccinated adequately against hepatitis B: a retrospective cohort study.
    Zheng YB; Gu YR; Zhang M; Wang K; Huang ZL; Lin CS; Gao ZL
    BMC Infect Dis; 2015 Nov; 15():542. PubMed ID: 26590815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I clinical trial in healthy adults of a nasal vaccine candidate containing recombinant hepatitis B surface and core antigens.
    Betancourt AA; Delgado CA; Estévez ZC; Martínez JC; Ríos GV; Aureoles-Roselló SR; Zaldívar RA; Guzmán MA; Baile NF; Reyes PA; Ruano LO; Fernández AC; Lobaina-Matos Y; Fernández AD; Madrazo AI; Martínez MI; Baños ML; Alvarez NP; Baldo MD; Mestre RE; Pérez MV; Martínez ME; Escobar DA; Guanche MJ; Cáceres LM; Betancourt RS; Rando EH; Nieto GE; González VL; Rubido JC
    Int J Infect Dis; 2007 Sep; 11(5):394-401. PubMed ID: 17257877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for lack of detectable antibody following hepatitis B vaccination of Minnesota health care workers.
    Wood RC; MacDonald KL; White KE; Hedberg CW; Hanson M; Osterholm MT
    JAMA; 1993 Dec 22-29; 270(24):2935-9. PubMed ID: 8254853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of hepatitis B (HB) vaccine non-responsiveness among health care workers from an endemic area (Taiwan).
    Yen YH; Chen CH; Wang JH; Lee CM; Changchien CS; Lu SN
    Liver Int; 2005 Dec; 25(6):1162-8. PubMed ID: 16343067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective clinical trial of hepatitis B vaccination in adults with and without type-2 diabetes mellitus.
    Van Der Meeren O; Peterson JT; Dionne M; Beasley R; Ebeling PR; Ferguson M; Nissen MD; Rheault P; Simpson RW; De Ridder M; Crasta PD; Miller JM; Trofa AF
    Hum Vaccin Immunother; 2016 Aug; 12(8):2197-2203. PubMed ID: 27123743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B infection awareness, vaccine perceptions and uptake, and serological profile of a group of health care workers in Yaoundé, Cameroon.
    Tatsilong HO; Noubiap JJ; Nansseu JR; Aminde LN; Bigna JJ; Ndze VN; Moyou RS
    BMC Public Health; 2016 Aug; 15():706. PubMed ID: 27487845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B virus vaccine in chronic kidney disease: improved immunogenicity by adjuvants? A meta-analysis of randomized trials.
    Fabrizi F; Dixit V; Messa P; Martin P
    Vaccine; 2012 Mar; 30(13):2295-300. PubMed ID: 22285268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of hepatitis B virus infection among health care workers in a tertiary hospital in Tanzania.
    Mueller A; Stoetter L; Kalluvya S; Stich A; Majinge C; Weissbrich B; Kasang C
    BMC Infect Dis; 2015 Sep; 15():386. PubMed ID: 26399765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity of a two-dose investigational hepatitis B vaccine, HBsAg-1018, using a toll-like receptor 9 agonist adjuvant compared with a licensed hepatitis B vaccine in adults.
    Jackson S; Lentino J; Kopp J; Murray L; Ellison W; Rhee M; Shockey G; Akella L; Erby K; Heyward WL; Janssen RS;
    Vaccine; 2018 Jan; 36(5):668-674. PubMed ID: 29289383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low levels of awareness, vaccine coverage, and the need for boosters among health care workers in tertiary care hospitals in India.
    Sukriti ; Pati NT; Sethi A; Agrawal K; Agrawal K; Kumar GT; Kumar M; Kaanan AT; Sarin SK
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1710-5. PubMed ID: 18761556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anti-HBs persistence following primary vaccination with three doses of hepatitis B vaccine among normal and high-responder adults: a 3-year follow-up study].
    Lyu JJ; Zhang L; Yan BY; Liu JY; Feng Y; Song LZ; Chen SY; Zhou LB; Liang XF; Cui FQ; Wang FZ; Xu AQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Jun; 50(6):478-83. PubMed ID: 27256725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High prevalence of active and occult hepatitis B virus infections in healthcare workers from two provinces of South Africa.
    Sondlane TH; Mawela L; Razwiedani LL; Selabe SG; Lebelo RL; Rakgole JN; Mphahlele MJ; Dochez C; De Schryver A; Burnett RJ
    Vaccine; 2016 Jul; 34(33):3835-9. PubMed ID: 27265453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistence of protection to hepatitis B vaccine and response to booster dose among children and adolescents in Dakahleya- Egypt.
    Salama II; Sami SM; Salama SI; Foud WA; Abdel Hamid AT; Said ZN
    Egypt J Immunol; 2014; 21(1):13-26. PubMed ID: 25204041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of non-responsiveness to an indigenous recombinant hepatitis B vaccine: a study among South Indian health care workers in a tertiary hospital.
    Thomas RJ; Fletcher GJ; Kirupakaran H; Chacko MP; Thenmozhi S; Eapen CE; Chandy G; Abraham P
    Indian J Med Microbiol; 2015 Feb; 33 Suppl():32-6. PubMed ID: 25657153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased immunogenicity of recombinant hepatitis B vaccine in chronic hepatitis C.
    Wiedmann M; Liebert UG; Oesen U; Porst H; Wiese M; Schroeder S; Halm U; Mössner J; Berr F
    Hepatology; 2000 Jan; 31(1):230-4. PubMed ID: 10613751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of immune response to hepatitis B vaccine in healthcare workers at a tertiary care hospital.
    Basireddy P; Avileli S; Beldono N; Gundela SL
    Indian J Med Microbiol; 2018; 36(3):397-400. PubMed ID: 30429394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knowledge, attitudes, and practices regarding hepatitis B vaccination among hospital-based doctors and nurses in China: Results of a multi-site survey.
    Liu Y; Ma C; Jia H; Xu E; Zhou Y; Zhang Z; Lu L; Rodewald L; Hao L
    Vaccine; 2018 Apr; 36(17):2307-2313. PubMed ID: 29567035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.